U-TRIAL offers candidates an opportunity to increase their impact. It builds on a strong scientific basis in all six priority fields. Present infrastructure includes the Julius Center, renowned for its multidisciplinary methodology for clinical research, where the head of U-TRIAL will be appointed. It further builds on Julius Clinical Ltd., the Academic Research Organization, proven capable of design and execution of international trials with impact. The appointed candidates will have the opportunity to assume a part-time appointment as scientific officer at Julius Clinical.
Applications are invited for exciting new posts at the University Medical Center Utrecht (UMC Utrecht), for its newly established Utrecht Trial Innovation Alliance (U-TRIAL) initiative. U-TRIAL is designed to strengthen the UMC Utrecht’s pursuit of ambitious goals in late phase clinical trials in its priority fields: Circulatory Health, Brain, Cancer, Infections & Immunity, Regenerative Medicine and Child Health. The board of directors of the UMC Utrecht strategically invests in U-TRIAL to increase the number of high quality, high impact clinical trials initiated and/or conducted by the UMC Utrecht. This will include clinical trials sponsored by pharmaceutical companies as well as investigator initiated and governmental (such as European Union or National Institutes of Health) funded trials.
The head of U-TRIAL, the 6 professors of clinical trials together with the professor of clinical trial methodology and the chief scientific officer of Julius Clinical will form the management team that has the authority and means to achieve the clinical trial goals set by the UMC Utrecht.
In each of these 6 priority fields a senior research position is available, for well qualified medical specialists with a strong track record in clinical trials (preferably including late phase trials) in their respective fields. Successful candidates are expected to have ambition and vision for developing and implementing a clinical trials portfolio with both global scientific impact as well as impact on healthcare. They have already proven their drive and ability, as evidenced by completed and published trials that impacted healthcare. They will work closely with colleagues in the UMC Utrecht to implement innovative and highly relevant clinical trials.
To complete the U-TRIAL team, the position of an overall head of U-TRIAL is open. In addition to the qualifications above, candidates for this position are proven successful leaders, capable of managing a large portfolio of clinical trials. They are expected to have a cross cutting vision and a well-established and productive international network with academic, industry and other funding bodies.
The salary for this 100% function is still to be determined. This job is based on a temporary position for 5 years.
Depending on your experience will be considered which position and salary scale is appropriate for your activities at U-TRIAL. For more information, you can contact Prof.dr. A.W. Hoes in July (088 756 8193 or email@example.com) or Prof.dr. K.C.B. Roes in August (088 756 8295 or firstname.lastname@example.org). Please submit your application to both professors. Formal job interviews will take place in September.
If you have any questions about this vacancy, please contact Mr.Prof dr A.W. Hoes, Voorzitter divisie Julius Centrum, phone 088 756 8193. Email email@example.com.
Acquisition based on this jobopening is not appreciated.